Opinion Pharmaceutical milestones: 250 million doses of vaccines and enhanced legal framework amid COVID-19
Media-OutReach Newswire As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)